Story perspectives

Trump Orders FDA to Crack Down on Deceptive Drug Ads

9/12/2025

33 6

Summary

Story summary

On September 9, 2025, President Trump directed the FDA to enforce restrictions on direct-to-consumer (DTC) pharmaceutical ads, especially on TV.
The FDA announced a crackdown on "deceptive" DTC ads, citing their impact on doctor-patient relationships.
FDA Commissioner Marty Makary acknowledged previous lax enforcement.
The FDA issued about 100 cease-and-desist letters without detailing specific violations.
The U.S. continues to allow DTC ads, alongside New Zealand, while balancing benefits and risks in advertising.

1 of 1

Story summary

On September 9, 2025, President Trump directed the FDA to enforce restrictions on direct-to-consumer (DTC) pharmaceutical ads, especially on TV.
The FDA announced a crackdown on "deceptive" DTC ads, citing their impact on doctor-patient relationships.
FDA Commissioner Marty Makary acknowledged previous lax enforcement.
The FDA issued about 100 cease-and-desist letters without detailing specific violations.
The U.S. continues to allow DTC ads, alongside New Zealand, while balancing benefits and risks in advertising.